Login Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective

Neurosteroid Modulation of GABAA Receptor Function by Independent Action at Multiple Specific Binding Sites

Author(s): Lei Wang, Douglas F. Covey, Gustav Akk and Alex S. Evers*

Volume 20, Issue 5, 2022

Published on: 01 March, 2022

Page: [886 - 890] Pages: 5

DOI: 10.2174/1570159X19666211202150041

Abstract

Neurosteroids are endogenous modulators of GABAA receptors that mediate anxiety, pain, mood and arousal. The 3-hydroxyl epimers, allopregnanolone (3α-OH) and epiallopregnanolone (3β-OH) are both prevalent in the mammalian brain and produce opposite effects on GABAA receptor function, acting as positive and negative allosteric modulators, respectively. This Perspective provides a model to explain the actions of 3α-OH and 3β-OH neurosteroids. The model is based on evidence that the neurosteroid epimers bind to an overlapping subset of specific sites on GABAA receptors, with their net functional effect on channel gating being the sum of their independent effects at each site.

Keywords: Neurosteroids, GABAA receptors, ion channels, affinity labeling, desensitization, structural biology.

« Previous Next »
[1]
Tuem, K.B.; Atey, T.M. Neuroactive steroids: Receptor interactions and responses. Front. Neurol., 2017, 8, 442.
[http://dx.doi.org/10.3389/fneur.2017.00442] [PMID: 28894435]
[2]
Majewska, M.D.; Harrison, N.L.; Schwartz, R.D.; Barker, J.L.; Paul, S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science, 1986, 232(4753), 1004-1007.
[http://dx.doi.org/10.1126/science.2422758] [PMID: 2422758]
[3]
Wang, M.; He, Y.; Eisenman, L.N.; Fields, C.; Zeng, C.M.; Mathews, J.; Benz, A.; Fu, T.; Zorumski, E.; Steinbach, J.H.; Covey, D.F.; Zorumski, C.F.; Mennerick, S. 3beta-hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J. Neurosci., 2002, 22(9), 3366-3375.
[http://dx.doi.org/10.1523/JNEUROSCI.22-09-03366.2002] [PMID: 11978813]
[4]
Majewska, M.D.; Mienville, J.M.; Vicini, S. Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci. Lett., 1988, 90(3), 279-284.
[http://dx.doi.org/10.1016/0304-3940(88)90202-9] [PMID: 3138576]
[5]
Belelli, D.; Lambert, J.J. Neurosteroids: Endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci., 2005, 6(7), 565-575.
[http://dx.doi.org/10.1038/nrn1703] [PMID: 15959466]
[6]
Olsen, R.W. GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology, 2018, 136(Pt A), 10-22.
[http://dx.doi.org/10.1016/j.neuropharm.2018.01.036] [PMID: 29407219]
[7]
Harrison, N.L.; Simmonds, M.A. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res., 1984, 323(2), 287-292.
[http://dx.doi.org/10.1016/0006-8993(84)90299-3] [PMID: 6098342]
[8]
Twyman, R.E.; Macdonald, R.L. Neurosteroid regulation of GABAA receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J. Physiol., 1992, 456, 215-245.
[http://dx.doi.org/10.1113/jphysiol.1992.sp019334] [PMID: 1338096]
[9]
Akk, G.; Bracamontes, J.R.; Covey, D.F.; Evers, A.; Dao, T.; Steinbach, J.H. Neuroactive steroids have multiple actions to potentiate GABAA receptors. J. Physiol., 2004, 558(Pt 1), 59-74.
[http://dx.doi.org/10.1113/jphysiol.2004.066571] [PMID: 15146041]
[10]
Akk, G.; Covey, D.F.; Evers, A.S.; Mennerick, S.; Zorumski, C.F.; Steinbach, J.H. Kinetic and structural determinants for GABA-A receptor potentiation by neuroactive steroids. Curr. Neuropharmacol., 2010, 8(1), 18-25.
[http://dx.doi.org/10.2174/157015910790909458] [PMID: 20808543]
[11]
Lan, N.C.; Gee, K.W.; Bolger, M.B.; Chen, J.S. Differential responses of expressed recombinant human gamma-aminobutyric acidA receptors to neurosteroids. J. Neurochem., 1991, 57(5), 1818-1821.
[http://dx.doi.org/10.1111/j.1471-4159.1991.tb06388.x] [PMID: 1655982]
[12]
Turner, D.M.; Ransom, R.W.; Yang, J.S.; Olsen, R.W. Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates. J. Pharmacol. Exp. Ther., 1989, 248(3), 960-966.
[PMID: 2539464]
[13]
Peters, J.A.; Kirkness, E.F.; Callachan, H.; Lambert, J.J.; Turner, A.J. Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids. Br. J. Pharmacol., 1988, 94(4), 1257-1269.
[http://dx.doi.org/10.1111/j.1476-5381.1988.tb11646.x] [PMID: 2850060]
[14]
Akk, G.; Germann, A.L.; Sugasawa, Y.; Pierce, S.R.; Evers, A.S.; Steinbach, J.H. Enhancement of muscimol binding and gating by allosteric modulators of the GABAA receptor: Relating occupancy to state functions. Mol. Pharmacol., 2020, 98(4), 303-313.
[http://dx.doi.org/10.1124/molpharm.120.000066] [PMID: 32873746]
[15]
Evers, A.S.; Chen, Z-W.; Manion, B.D.; Han, M.; Jiang, X.; Darbandi-Tonkabon, R.; Kable, T.; Bracamontes, J.; Zorumski, C.F.; Mennerick, S.; Steinbach, J.H.; Covey, D.F. A synthetic 18-norsteroid distinguishes between two neuroactive steroid binding sites on GABAA receptors. J. Pharmacol. Exp. Ther., 2010, 333(2), 404-413.
[http://dx.doi.org/10.1124/jpet.109.164079] [PMID: 20124410]
[16]
Sapp, D.W.; Witte, U.; Turner, D.M.; Longoni, B.; Kokka, N.; Olsen, R.W. Regional variation in steroid anesthetic modulation of [35S]TBPS binding to gamma-aminobutyric acidA receptors in rat brain. J. Pharmacol. Exp. Ther., 1992, 262(2), 801-808.
[PMID: 1323664]
[17]
Hosie, A.M.; Wilkins, M.E.; da Silva, H.M.; Smart, T.G. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature, 2006, 444(7118), 486-489.
[http://dx.doi.org/10.1038/nature05324] [PMID: 17108970]
[18]
Chen, Z.W.; Manion, B.; Townsend, R.R.; Reichert, D.E.; Covey, D.F.; Steinbach, J.H.; Sieghart, W.; Fuchs, K.; Evers, A.S. Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor. Mol. Pharmacol., 2012, 82(3), 408-419.
[http://dx.doi.org/10.1124/mol.112.078410] [PMID: 22648971]
[19]
Chen, Z.W.; Bracamontes, J.R.; Budelier, M.M.; Germann, A.L.; Shin, D.J.; Kathiresan, K.; Qian, M.X.; Manion, B.; Cheng, W.W.L.; Reichert, D.E.; Akk, G.; Covey, D.F.; Evers, A.S. Multiple functional neurosteroid binding sites on GABAA receptors. PLoS Biol., 2019, 17(3)e3000157
[http://dx.doi.org/10.1371/journal.pbio.3000157] [PMID: 30845142]
[20]
Jayakar, S.S.; Chiara, D.C.; Zhou, X.; Wu, B.; Bruzik, K.S.; Miller, K.W.; Cohen, J.B. Photoaffinity labeling identifies an intersubunit steroid-binding site in heteromeric GABA type A (GABAA) receptors. J. Biol. Chem., 2020, 295(33), 11495-11512.
[http://dx.doi.org/10.1074/jbc.RA120.013452] [PMID: 32540960]
[21]
Laverty, D.; Thomas, P.; Field, M.; Andersen, O.J.; Gold, M.G.; Biggin, P.C.; Gielen, M.; Smart, T.G. Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites. Nat. Struct. Mol. Biol., 2017, 24(11), 977-985.
[http://dx.doi.org/10.1038/nsmb.3477] [PMID: 28967882]
[22]
Miller, P.S.; Scott, S.; Masiulis, S.; De Colibus, L.; Pardon, E.; Steyaert, J.; Aricescu, A.R. Structural basis for GABAA receptor potentiation by neurosteroids. Nat. Struct. Mol. Biol., 2017, 24(11), 986-992.
[http://dx.doi.org/10.1038/nsmb.3484] [PMID: 28991263]
[23]
Chen, Q.; Wells, M.M.; Arjunan, P.; Tillman, T.S.; Cohen, A.E.; Xu, Y.; Tang, P. Structural basis of neurosteroid anesthetic action on GABAA receptors. Nat. Commun., 2018, 9(1), 3972.
[http://dx.doi.org/10.1038/s41467-018-06361-4] [PMID: 30266951]
[24]
Ziemba, A.M.; Szabo, A.; Pierce, D.W.; Haburcak, M.; Stern, A.T.; Nourmahnad, A.; Halpin, E.S.; Forman, S.A. Alphaxalone binds in inner transmembrane beta+-alpha- interfaces of alpha1beta3gamma2 gamma-aminobutyric acid type A receptors. Anesthesiology, 2018, 128(2), 338-351.
[http://dx.doi.org/10.1097/ALN.0000000000001978] [PMID: 29210709]
[25]
Akk, G.; Li, P.; Bracamontes, J.; Reichert, D.E.; Covey, D.F.; Steinbach, J.H. Mutations of the GABA-A receptor α1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol. Pharmacol., 2008, 74(3), 614-627.
[http://dx.doi.org/10.1124/mol.108.048520] [PMID: 18544665]
[26]
Sugasawa, Y.; Cheng, W.W.; Bracamontes, J.R.; Chen, Z.W.; Wang, L.; Germann, A.L.; Pierce, S.R.; Senneff, T.C.; Krishnan, K.; Reichert, D.E.; Covey, D.F.; Akk, G.; Evers, A.S. Site-specific effects of neurosteroids on GABAA receptor activation and desensitization. eLife, 2020, 9e55331
[http://dx.doi.org/10.7554/eLife.55331] [PMID: 32955433]
[27]
Germann, A.L.; Pierce, S.R.; Tateiwa, H.; Sugasawa, Y.; Reichert, D.E.; Evers, A.S.; Steinbach, J.H.; Akk, G. Intrasubunit and intersubunit steroid binding sites independently and additively mediate α1β2γ2L GABAA receptor potentiation by the endogenous neurosteroid allopregnanolone. Mol. Pharmacol., 2021, 100(1), 19-31.
[http://dx.doi.org/10.1124/molpharm.121.000268] [PMID: 33958479]
[28]
Sugasawa, Y.; Bracamontes, J.R.; Krishnan, K.; Covey, D.F.; Reichert, D.E.; Akk, G.; Chen, Q.; Tang, P.; Evers, A.S.; Cheng, W.W.L. The molecular determinants of neurosteroid binding in the GABA(A) receptor. J. Steroid Biochem. Mol. Biol., 2019, 192105383
[http://dx.doi.org/10.1016/j.jsbmb.2019.105383] [PMID: 31150831]
[29]
Chisari, M.; Eisenman, L.N.; Krishnan, K.; Bandyopadhyaya, A.K.; Wang, C.; Taylor, A.; Benz, A.; Covey, D.F.; Zorumski, C.F.; Mennerick, S. The influence of neuroactive steroid lipophilicity on GABAA receptor modulation: Evidence for a low-affinity interaction. J. Neurophysiol., 2009, 102(2), 1254-1264.
[http://dx.doi.org/10.1152/jn.00346.2009] [PMID: 19553485]
[30]
Li, P.; Shu, H.J.; Wang, C.; Mennerick, S.; Zorumski, C.F.; Covey, D.F.; Steinbach, J.H.; Akk, G. Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation. J. Physiol., 2007, 584(Pt 3), 789-800.
[http://dx.doi.org/10.1113/jphysiol.2007.142794] [PMID: 17761771]
[31]
Sooksawate, T.; Simmonds, M.A. Influence of membrane cholesterol on modulation of the GABA(A) receptor by neuroactive steroids and other potentiators. Br. J. Pharmacol., 2001, 134(6), 1303-1311.
[http://dx.doi.org/10.1038/sj.bjp.0704360] [PMID: 11704651]
[32]
Lee, A.G. Interfacial binding sites for cholesterol on GABAA receptors and competition with neurosteroids. Biophys. J., 2021, 120(13), 2710-2722.
[http://dx.doi.org/10.1016/j.bpj.2021.05.009] [PMID: 34022235]
[33]
Budelier, M.M.; Cheng, W.W.L.; Chen, Z.W.; Bracamontes, J.R.; Sugasawa, Y.; Krishnan, K.; Mydock-Magrane, L.; Covey, D.F.; Evers, A.S. Common binding sites for cholesterol and neurosteroids on a pentameric ligand-gated ion channel. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 2019, 1864, 128-136.
[http://dx.doi.org/10.1016/j.bbalip.2018.11.005] [PMID: 30471426]

Rights & Permissions Print Cite
Article Metrics
56
1
World Autism Awareness Day
© 2024 Bentham Science Publishers | Privacy Policy